Clinical observation of qingxue granules in treating post-nephrotransplantation erythrocytosis.
- Author:
Lin-lin MA
1
;
Yu-fei YANG
;
Yu WU
;
Xianwen WU
;
Xiaoping YAN
;
Yuhai ZHANG
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Drugs, Chinese Herbal; therapeutic use; Female; Humans; Kidney Transplantation; adverse effects; Male; Middle Aged; Phytotherapy; Polycythemia; drug therapy; etiology
- From: Chinese Journal of Integrated Traditional and Western Medicine 2005;25(10):934-936
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the therapeutic efficacy of Qingxue Granules (QX) in treating postnephrotransplant erythrocytosis (PNTE).
METHODSTwenty patients were randomly divided into two groups according to the randomized table. QX was given to patients in the TCM treated group (QX group) and Enalapril given to patients in the Western medicine treated group (WM group), and the clinical efficacy in the two groups was observed. Results In the QX group, 3 patients got markedly effective, 2 effective, 2 improved, 1 ineffective, 1 dropped from the treatment, 1 absconded, with the total effective rate of 77.78%. The corresponding numbers in the WM group were 4, 2, 2, 1, 1 and 66.67%. There was no significant difference in comparison of the efficacies between the two groups (P > 0.05). There was no difference between the Intent-to-Treat population and Per-protocol Pouplation after statistical management of lost cases.
CONCLUSIONIt has proved that QX has the same therapeutic effects as classic Western medical treatment in treating PNTE. The reliability and scientificity of QX was proved by Intent-to-Treat analysis.
